Recently Viewed 0
Meet Clearsynth at CPHI Milan · October 6–8, 2026 · Booth 10F24 Book a meeting
My Account Need quick assistance? WhatsApp us +91-22-45045900 sales@clearsynth.com
Clearsynth API development and manufacturing campus
API development and supply

Deuterated APIs

Development and manufacturing support for active pharmaceutical ingredients in which selected hydrogen atoms are replaced with deuterium.

Definition

What is a deuterated API?

A deuterated API is an active pharmaceutical ingredient with deuterium incorporated at one or more defined positions. The substitution changes isotopic composition without changing the element itself. Its practical effect depends on the molecular structure, incorporation site, exchange liability, route, dose form and intended use; it must be evaluated for the individual compound.

Program requirements

From isotope strategy to a controlled process

A deuterated drug-substance program has two connected problems: establishing the required isotopic outcome and developing chemistry that remains practical at the intended scale.

1

Position and route

Review of the proposed deuteration site, metabolic rationale, synthetic access, deuterium source and opportunities for exchange or isotope loss.

2

Chemical and isotopic quality

Methods are selected to examine identity, chemical purity, isotopic enrichment, residual protium and relevant isotopologue distribution.

3

Process scale

Reaction conditions, work-up, isolation, drying, raw materials and equipment fit are developed together so the isotope result survives scale-up.

Clearsynth support

Development, analytics and manufacturing

Clearsynth connects deuterium chemistry with process development, analytical science and manufacturing. Work is defined around the molecule, current development stage, target quantity, required documentation and destination market.

  • Route assessment and isotope-incorporation studies
  • Process optimization, impurity understanding and scale-up
  • Analytical methods for chemical and isotopic attributes
  • Technology transfer and manufacturing preparation
  • Quality documentation and project-specific supply planning
Clearsynth scientists reviewing API development data
Analytical control

Measurements needed for the molecule

QuestionTypical evidenceWhy it matters
Is the intended API present?Chromatographic, mass-spectrometric and spectroscopic identity dataConfirms chemical identity and distinguishes the target from related material.
Where is deuterium located?NMR, MS and other fit-for-purpose structural evidenceSupports positional assignment and helps identify scrambling.
How much isotope is present?Isotopic enrichment and isotopologue assessmentDefines the isotope-related quality attribute for the program.
Will the label remain?Exchange, process, work-up, drying and stability observationsIdentifies conditions that may cause back-exchange or loss.
Is chemical purity controlled?Assay, related substances, residual solvents and project-specific testsConnects isotope control with conventional API quality requirements.
Program-specific scope: test methods, specifications and regulatory documentation are agreed for the molecule and development phase. A deuterated compound should not be assumed to have a particular clinical or metabolic outcome solely because deuterium is present.

Discuss a deuterated API program

Share the structure, proposed isotope position, development stage, target scale, analytical expectations and required timeline.

Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.